Back

Predictors of ICD therapy in cardiac sarcoidosis patients within large metropolitan population

1 September 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Shocking news regarding implantable cardioverter-defibrillator therapy Implantable Cardioverter-Defibrillator (ICD) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speakers

Photo
Doctor Namhee Kim

Mount Sinai St Luke's and Mount Sinai West Hospital, New York (United States of America)

Photo
Doctor Sabrina Daoui

Mount Sinai Fuster Heart Hospital, New York City (United States of America)

7 More presentations in this session

Presentation thumbnail
Head-to-head comparison of single- versus dual-chamber ICD discriminators for tachyarrhythmia detection: a remote monitoring based, bicentric study
Doctor F. Gausz (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Evaluation of defibrillation thresholds in extravascular defibrillators: results from a monocenter prospective study
Doctor A. Quaranta (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Feasibility of extravascular defibrillator implantation in a fully cardiological setting: from general anesthesia to deep sedation, and relevance of surgical back-up
Doctor A. Quaranta (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes after implantable cardioverter-defibrillator therapy in patients with chronic Chagas cardiomyopathy: an updated systematic review and meta-analysis
Doctor I. Ferreira Felix (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Smartpass 2.0 in subcutaneous implantable cardioverter defibrillator: T-wave oversensing no longer the primary cause of inappropriate shocks
Mr C. Monkhouse (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Shocking news regarding implantable cardioverter-defibrillator therapy

The Event

Event poster

ESC Congress 2025

1 September 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic factors of fatal ventricular arrhythmias in cardiac sarcoidosis patients without a history of ventricular arrhythmias: insights from nationwide registry
thumbnail
Congress Presentation
Predictors of implantable cardioverter-defibrillator therapies: a 6-year follow-up study
thumbnail
Congress Presentation
Long-term prognostic value of scar characteristics in cardiac magnetic resonance to predict appropriate therapies in primary prevention

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources